Skip to content

TARGET: Targeted depression prevention program for at-risk adolescents

Prevention of major depression in at-risk adolescents: a pilot randomised controlled trial of a screen-and-intervene program

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN95425657
Enrollment
250
Registered
2013-06-28
Start date
2013-09-01
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression Mental and Behavioural Disorders Depressive episode, unspecified

Interventions

Randomised controlled trial comparing Coping with Stress group to Usual Care control. Randomisation stratifying for age, gender, initial symptom severity and parental depression severity.

Sponsors

King's College London (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Stage 1: Adults: 1. Current or past diagnosis of an affective disorder (i.e. a major depressive episode in the last 3 years OR >= 3 major depressive episodes or >= 3 cumulative years in a major depressive or dysthymic episode in the young person's lifetime) 2. Have a son or daughter between 10-17 years old Young people: 1. Aged between 10-17 years old 2. Able to read English Stage 2: 1. Young people: aged between 10-17 years old 2. Able to read English 3. MFQ score 20-29 or previous diagnosis of Major Depressive Disorder

Exclusion criteria

Exclusion criteria: Stage 1: Adults: past or current diagnosis of bipolar affective disorder or schizoaffective disorder Stage 2: Young people: Current diagnosis of major depressive disorder (determined by clinical interview KSADS); another primary disorder in need of treatment

Design outcomes

Primary

MeasureTime frame
LIFE Interview; Timepoint(s): Post CBT group and at 6-month follow-up

Secondary

MeasureTime frame
1. Children's Depression Rating Scale (CDRS); Timepoint(s): The CDRS is to be administered pre and post group, and at 6-month follow-up 2. Moods and Feelings Questionnaire (MFQ); Timepoint(s): The MFQ is to be administered pre and post group, and at 6-month follow-up 3. Screen for Anxiety and Related Disorders in Childhood (SCARED-C); Timepoint(s): The scared will be administered pre and post group, and at 6-month follow-up 4. Strengths and Difficulties Questionnaire (SDQ); Timepoint(s): The SDQ will be administered pre and post group, and at 6-month follow-up

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026